Table 4.
Diabetic + control participants | ||
---|---|---|
eGFR |
||
R | p value | |
1,25(OH)2D3 | 0.141 | 0.001 |
25(OH)D3 | −0.028 | 0.461 |
24,25(OH)2D3 | 0.096 | 0.012 |
Diabetic patients | ||
eGFR |
||
R | p value | |
1,25(OH)2D3 | 0.067 | 0.242 |
25(OH)D3 | −0.032 | 0.507 |
24,25(OH)2D3 | 0.148 | 0.002 |
Controls | ||
eGFR |
||
R | p value | |
1,25(OH)2D3 | 0.108 | 0.119 |
25(OH)D3 | −0.112 | 0.076 |
24,25(OH)2D3 | −0.063 | 0.324 |
eGFR, estimated glomerular filtration rate; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; 25(OH)D3, 25-hydroxyvitamin D3; 24,25(OH)2D3, 24,25-dihydroxyvitamin D3.